SECOND SIGHT MEDICAL PRODUCTS INC·4

Dec 4, 5:34 PM ET

Randolph Edward David 4

4 · SECOND SIGHT MEDICAL PRODUCTS INC · Filed Dec 4, 2017

Insider Transaction Report

Form 4
Period: 2017-12-01
Randolph Edward David
VP of Manufacturing
Transactions
  • Award

    Common Stock

    2017-12-01$1.25/sh18,553$23,19122 total
  • Award

    Common Stock

    2017-11-30$0.96/sh+18,553$17,81118,575 total
Holdings
  • Non-Qualified Stock Option (right to buy)

    Exercise: $5.00From: 2013-03-01Exp: 2022-03-01Common Stock (7,750 underlying)
    7,750
  • Non-Qualified Stock Option (right to buy)

    Exercise: $4.10From: 2017-01-21Exp: 2026-01-21Common Stock (11,513 underlying)
    11,513
  • Non-Qualified Stock Option (right to buy)

    Exercise: $5.00From: 2012-03-01Exp: 2021-03-01Common Stock (8,313 underlying)
    8,313
  • Non-Qualified Stock Option (right to buy)

    Exercise: $1.97From: 2018-01-03Exp: 2027-01-03Common Stock (151,170 underlying)
    151,170
  • Non-Qualified Stock Option (right to buy)

    Exercise: $5.00From: 2009-02-01Exp: 2018-02-01Common Stock (2,290 underlying)
    2,290
  • Non-Qualified Stock Option (right to buy)

    Exercise: $5.00From: 2015-04-01Exp: 2024-04-01Common Stock (10,937 underlying)
    10,937
  • Non-Qualified Stock Option (right to buy)

    Exercise: $13.09From: 2016-03-25Exp: 2025-03-25Common Stock (6,250 underlying)
    6,250
  • Non-Qualified Stock Option (right to buy)

    Exercise: $5.00From: 2009-11-01Exp: 2018-11-01Common Stock (25,000 underlying)
    25,000
  • Non-Qualified Stock Option (right to buy)

    Exercise: $5.00From: 2010-02-01Exp: 2019-02-01Common Stock (6,750 underlying)
    6,750
  • Non-Qualified Stock Option (right to buy)

    Exercise: $5.00From: 2011-02-01Exp: 2020-02-01Common Stock (20,750 underlying)
    20,750
  • Non-Qualified Stock Option (right to buy)

    Exercise: $9.00From: 2015-09-26Exp: 2024-09-26Common Stock (65,895 underlying)
    65,895
Footnotes (3)
  • [F1]18,553 shares, acquired as part of scheduled ESSP purchases on 11/30/2017 and sold on 12/1/2017.
  • [F2]Options vest over a four year term of which one-fourth vests on the Date Exercisable, with the remaining options vesting quarterly over three years thereafter.
  • [F3]Options vest in 4 yearly increments starting with the Date Exercisable.

Documents

1 file
  • 4
    s108332_form4.xmlPrimary

    OWNERSHIP DOCUMENT